Group One Trading
WHWK

Group One Trading’s Whitehawk Therapeutics WHWK Stock Holding History

Group One Trading’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100
Closed -$313 – 9040
2025
Q4 		$242 Buy
+100
New +$229 ﹤0.01% 7874
2025
Q1 		– Sell
-500
Closed -$1.31K – 8533
2024
Q4 		$1.58K Buy
+500
New +$1.13K ﹤0.01% 6799
2024
Q1 		– Sell
-1,836
Closed -$3.54K – 8125
2023
Q4 		$3.71K Buy
+1,836
New +$7.7K ﹤0.01% 6625

Other funds holding WHWK

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Group One Trading's WHWK Position: Q1 2026 in Review

Group One Trading sold out of Whitehawk Therapeutics (WHWK) in Q1 2026, closing a stake of 100 shares — an estimated $313 sold.

Group One Trading first reported a position in WHWK in Q4 2023 and held it in 3 quarters. The position peaked at $3.71K in Q4 2023. 62 funds tracked by Wall St. Rank hold WHWK as of Q1 2026.

  • Group One Trading reported no remaining Whitehawk Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 100 Whitehawk Therapeutics shares in Q1 2026, an estimated $313.
  • Group One Trading first reported a position in Whitehawk Therapeutics in Q4 2023 and held it in 3 quarters.
  • Group One Trading's Whitehawk Therapeutics position peaked at $3.71K in Q4 2023.
  • 62 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.